# ALTO-300 in Depression (ALTO-300-004)

> **NCT05157945** · PHASE2 · COMPLETED · sponsor: **Alto Neuroscience** · enrollment: 148 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** ALTO-300 PO Tablet

## Key facts

- **NCT ID:** NCT05157945
- **Lead sponsor:** Alto Neuroscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-03
- **Primary completion:** 2023-04-26
- **Final completion:** 2023-05-05
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157945, "ALTO-300 in Depression (ALTO-300-004)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05157945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*